Restricted accessResearch articleFirst published online 2004-04
The Regulation of Interleukin-6 Secretion by Prostanoids and Members of the Tumor Necrosis Factor Superfamily in Fresh Villous Fragments of Term Human Placenta
Objective:To determine whether prostanoids, nonsteroidal anti-inflammatory drugs (NSAIDs), and members of the tumor necrosis factor superfamily can regulate placental secretion of interleukin-6 (IL-6) and whether labor influences any such effects.
Methods:Villous fragments of term, human placenta were kept in culture for up to 4 hours, and IL-6 concentrations were measured in the supermatant. We assessed the effects of the following prostanoids: PGE2, PGF2α, thromboxane A2 mimetic (U-46619), and carbacyclin, a stable prostacyclin analogue (all at 1 μM); NSAIDs: indomethacin (150 μM) or nimesulide (100 μM); and Fas ligand (5 ng/mL).
Results:Secretion (mean ± standard error) of IL-6 was, for control conditions, 1.92 ± 0.28 fmol/mg wet weight per 3 hours; for PGE2, 3.57 ± 0.29 fmol/mg wet weight per 3 hours, P < .01; and for carbacyclin, 3.11 ± 0.44 fmol/mg wet weight per 3 hours, P < .01. Incubation with PGF2α or the thromboxane A2 analogue, U46619, had no effect on IL-6 secretion under these conditions. Fas ligand stimulated IL-6 secretion (3.06 ± 0.38 fmol/mg wet weight per 3 hours, P < .05). Labor did not alter the effects of prostanoids or FasL. The effects of NSAIDs were assessed over 4 hours. Secretion (median, interquartile range) was, under control conditions 3.26, 2.83-6.23 fmol/mg wet weight per 4 hours, with indomethacin 1.4, 1.28-3.21 (P < .05), and with nimesulide 0.75, 0.50-1.56 fmol/mg wet weight per 4 hours. The magnitude of the effect of Fas ligand in the presence of NSAIDs depended on whether the placentas were delivered before or after labor.
Conclusion:Prostanoids, NSAIDs, and the Fas ligand regulate placental IL-6 secretion. Although the effects of individual agents did not vary with the presence or absence of labor, modulation of IL-6 secretion by labor became apparent when agents were combined.
1. Wu YW, Colford J. Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis. JAMA2000;284:1417-1424.
2.
2. Duggan PJ, Edwards AD. Placental inflammation and brain injury in preterm infants. Dev Med Child Neurol2001;86(Suppl):16-17.
3.
3. Redline RW, Wilson-Costello D, Borawski E, Fanaroff AA, Hack M. Placental lesions associated with neurologic impairment and cerebral palsy in very low-birth-weight infants. Arch Pathol Lab Med1998;122:1091-1098.
4.
4. Salafia CN, Minior VK, Rosenkrantz TS, et al. Maternal, placental and neonatal associations with early germinal matrix/intraventricular hemorrhage in infants born before 32 weeks gestation. Am J Perinatol1995;12:429-436.
5.
5. The Developmental Epidemiology Network Investigators. The correlation between placental pathology and intraventricular hemorrhage in the preterm infant. Pediatr Res1998;43:15-19.
6.
6. Yoon BH, Romero R, Yang SH, et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol1996;174:1433-1440.
7.
7. Nelson KB, Grether JK, Dambrosia JM, et al. Neonatal cytokines and cerebral palsy in very preterm infants. Pediatr Res2003;53:600-607.
8.
8. Li Y, Matsuzaki N, Masuhiro K, et al. Trophoblast-derived tumor necrosis factor-α induces release of human chorionic gonadotrophin using interleukin-6 (IL-6) and IL-6-receptor-dependent system in the normal human trophoblasts. J Clin Endocrinol Metab1992;74:184-191.
9.
9. Masuhiro K, Matsuzaki N, Nishino E, et al. Trophoblast-derived interleukin-1 (IL-1) stimulates the release of human chorionic gonadotrophin by activating IL-6 and IL-6-receptor system in first trimester human trophoblasts. J Clin Endocrinol Metab1991;72:594-601.
10.
10. Pierce BT, Pierce LM, Wagner RK, et al. Hypoperfusion causes increased production of interleukin 6 and tumor necrosis factor-α in the isolated, dually perfused placental cotyledom. Am J Obstet Gynecol2000;183:863-867.
11.
11. Turner MA, Shaikh SA, Greenwood SL. Secretion of interleukin 1β and interleukin-6 by fragments of term human placental villi: Signalling pathways and effects of tumor necrosis factor-α and mode of delivery. Placenta2002;23:467-474.
12.
12. Tavakoli S, Cowan MJ, Benfield T, Logun C, Shelhamer JH. Prostaglandin E2-induced interleukin-6 release by a human airway epithelial cell line. Am J Physiol2001;280:L127-L133.
13.
13. Takaoka Y, Niwa S, Nagai H. Interleukin-1β induces interleukin-6 production through the production of prostaglandin E2 in human osteoblasts, MG-63 cells. J Biochem1999;126:553-558.
14.
14. Gruber R, Nothegger G, Ho GM, Willheim M, Peterlik M. Differential stimulation by PGE2 and calcemic hormones of IL-6 in stromal/osteoblastic cells. Biochem Biophys Res Commun2000;270:1080-1085.
15.
15. Keelan JA, Sato TA, Gupta DP, Marvin KW, Mitchell MD. Prostanoid stimulation of cytokine production in an amnionderived cell line: Evidence of a feed-forward mechanism with implications for term and preterm labour. J Soc Gynecol Investig2000;7:37-44.
16.
16. Bennett PR, Henderson DJ, Moore GE. Changes in expression of the cyclooxygenase gene in human fetal membranes and placenta with labor. Am J Obstet Gynecol1992;167:212-216.
17.
17. Alfaidy N, Sun MY, Challis J, Gibb W. Expression of membrane prostaglandin e synthase in human planceta and fetal membranes and effect of labor. Endocrine2003;20:219-226.
18.
18. Schmitz H, Fromm M, Bode H, Scholz P, Riecken EO, Schulzke JD. Tumor necrosis factor induces Cl- and K+ secretion in human distal colon driven by prostaglandin E2. Am J Physiol1996;271:G669-G674.
19.
19. Hunt JS. Cytokine networks in the uteroplacental unit: Macrophages as pivotal regulatory cells. J Reprod Immunol1989;16:1-17.
20.
20. Sooranna SR, Oteng-Ntim E, Meah R, Ryder TA, Bajoria R. Characterization of human placental explants: Morphological, biochemical and physiological studies using first and third trimester placenta. Hum Reprod1999;14:536-541.
21.
21. Hunt JS, Phillips TA, Rasmussen CA, Bowen JA, Bluethmann H. Apoptosis-inducing members of the tumor necrosis factor supergene family: Potential function in placentae. Trophoblast Res1999;13:243-257.
22.
22. Nelson DP, Setser E, Hall DG, et al. Proinflammatory consequences of transgenic fas ligand expression in the heart. J Clin Invest2000;105:1199-1208.
23.
23. Balkundi DR, Hanna N, Hleb M, Dougherty J, Sharma S. Labor-associated changes in Fas ligand expression in human pregnancy. Pediatr Res2000;47:301-308.
24.
24. Doughty L, Clark RSB, Kaplan SS, Sasser H, Carcillo J. sFas and sFas ligand and pediatric sepsis-induced multiple organ failure syndrome. Pediatr Res2002;52:922-927.
25.
25. Marvin KW, Eykholt RL, Mitchell MD. Subcellular localization of prostaglandin H synthase-2 in a human amnion cell line: Implications for nuclear localized prostaglandin signaling pathways. Prostaglandin Leukotrienes Essential Fatty Acids2000;62:7-11.
26.
26. van Baal J, de Jong MD, Zijlstra FJ, Willems PHGM, Bindels RJM. Endogenously produced prostanoids stimulate calcium reabsorption in the rabbit cortical collecting system. J Physiol1996;497:229-239.
27.
27. Kang IS, Siler-Khodr TM. Effect of exogenous arachidonic acid and enzyme inhibitors on placental prostanoid production. Placenta1993;14:341-353.
28.
28. Tries S, Neupert W, Laufer S. The mechanism of action of the new antiinflammatory compound ML3000: Inhibition of 5-LOX and COX-1/2. Inflamm Res2002;51:135-143.
29.
29. Tavares IA. The effects of meloxicam, indomethacin or NS-398 on eicosanoid synthesis by fresh human gastric mucosa. Aliment Pharmacol Ther2000;14:795-799.
30.
30. Lopez CH, Bracht A, Yamamoto NS, Ishii-Iwamoto EL, Sampaio E, Kelmer-Bracht AM. The action of flufenamic acid and other nonsteroidal anti-inflammatories on sulfate transport in the isolated perfused rat liver. Gen Pharmacol1999;32:713-720.
31.
31. Kameda T, Matsuzaki N, Sawai K, et al. Production of interleukin-6 by normal human trophoblast. Placenta1990;11:205-213.
32.
32. Munno I, Chiechi LM, Lacedera G, et al. Spontaneous and induced release of prostaglandins, interleukin (IL)-1β, IL-6 and tumor necrosis factor-α by placental tissue from normal and pre-eclamptic pregnancies. Am J Reprod Immunol1994;42:369-374.
33.
33. Sastry BV, Hemontolor ME, Chance MB, Johnson RF. Dual messenger function for porstaglandin E2 (PGE2) in human placenta. Cell Mol Biol1997;43:417-424.
34.
34. Blumenstein M, Keelan JA, Mitchell MD. Hypoxia attenuates PGE2 but increases prostacyclin and thromboxane production in human term villous trophoblast. Placenta2001;22:519-526.
35.
35. Benyo DF, Miles TM, Conrad KP. Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab1997;82:1582-1588.
36.
36. Brownbill P, Sibley CP. U-46619 mediated vasoconstriction in the in vitro dually perfused human cotyledon—consequences on fetomaternal solvent transfer. J Soc Gynecol Investig2001;8:142A-142A.
37.
37. Payne SG, Smith SC, Davidge ST, Baker PN, Guilbert LJ. Death receptor Fas/Apo-1/CD95 expressed by human placental cytotrophoblasts does not mediate apoptosis. Biol Reprod1999;60:1144-1150.
38.
38. Knock GA, Aaronson PI. Calcium antagonistic properties of the cyclooxygenase-2 inhibitor nimesulide in human myometrial myocytes. Br J Pharmacol1999;127:1470-1478.
39.
39. Norwitz ER, Robinson JN, Challis JRG. The control of labour. N Engl J Med1999;341:660-666.
